Dentsply Sirona, the world’s largest manufacturer of professional dental products and technologies, expands the application range of its Primeprint Solution with the introduction of new resins to its portfolio. The recently FDA and CE cleared Primeprint Splint ST and Primeprint Splint SF resins cater to the needs of dental professionals seeking to create patient-specific nightguards and splints for various treatments, ensuring precise fits, high biocompatibility, and instilling confidence in their practice. These splints are increasingly in demand in dental practices, particularly for patients dealing with bruxism.
Utilizing the Primeprint Solution for manufacturing nightguards presents numerous advantages, coupled with the high degree of automation in the Dentsply Sirona 3D printing system. The innovative Primeprint Material Unit Type S and application-specific print processes reduce manual work, such as time-consuming polishing, making the results shiny after the post-curing process and easily detachable from support structures.
Primeprint Splint ST and Primeprint Splint SF resins offer the flexibility to be printed with thin wall thickness, starting at 0.8 mm. They present varying degrees of hardness and flexibility, allowing selection based on the indication and the patient’s needs. These resins are free of MMA, THF-MA, and TPO2, ensuring a neutral taste and scent for optimal patient wear comfort.
The new resins seamlessly integrate into the Primeprint 3D printing system, offering dental professionals flexibility in their workflows. Whether designing in-house using inLab Software, ordering from DS Core Create, or selecting their preferred dental lab, practitioners can benefit from simplified workflows. When utilizing DS Core Create design services, the splint design is delivered as a ready-to-print file within a six-hour turnaround time, streamlining production and facilitating easy delegation of the workflow to practice staff.
“Thanks to the new splint solution, I can now offer expanded indications for my patients with 3D printing,” explained Dr. Meena Barsoum, dentist from Arlington (USA), one of the first users of the new Primeprint Splint ST and Primeprint Splint SF resins. “I love how easy it is to remove the support structures after the automated post-processing in the PPU, and my patients appreciate both the wearing comfort and the esthetics.”
“This innovation is another step toward advancing automated 3D printing in practices and laboratories,” said Max Milz, group vice president connected technology solutions at Dentsply Sirona. “So dental 3D printing is once again proving to be a highly attractive technology that is particularly suitable for fabricating non-permanent removable applications such as splints, surgical guides and models and seamlessly complements existing methods.”
For more information, please visit https://www.dentsplysirona.com/en/discover/discover-by-brand/primeprint.html.
2 Methyl methacrylate (MMA), tetrahydrofurfuryl methacrylate (THF-MA) Thermoplastic polyolefins (TPO)
Registered brands, trade names and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials.
About Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands.
Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care.
Dentsply Sirona’s headquarter is located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY.
Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements.
In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market, and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.
Registered brands, trade names, and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials.